What is a GLP-1 medication?

GLP-1 receptor agonists are a class of medications originally developed for type 2 diabetes that have shown significant weight-loss benefits. They mimic a naturally occurring hormone that regulates appetite, slows stomach emptying, and helps control blood sugar. Common brand names include Ozempic, Wegovy, Mounjaro, and Zepbound.

How much weight can I lose on GLP-1 medications?

Clinical trials show that GLP-1 medications can lead to 15–22% body weight loss over 68 weeks when combined with lifestyle changes. Individual results vary based on dosage, diet, activity level, and adherence.

What should I eat while taking GLP-1 medications?

Prioritize high-protein foods to preserve muscle mass, fiber-rich vegetables for digestion, and adequate hydration. Avoid high-fat, fried, and very sugary foods, which can worsen nausea and other GI side effects.

What are the most common GLP-1 side effects?

The most frequently reported side effects are nausea, vomiting, diarrhea, constipation, and fatigue. These typically occur during dose escalation and subside as your body adjusts.

Do I need to exercise while on GLP-1s?

Yes. Strength training is especially important to preserve muscle mass during weight loss — without it, up to 40% of weight lost can be muscle. Aim for 2–3 resistance training sessions per week plus moderate cardio.

How do I track my GLP-1 progress effectively?

Tracking medication doses, side effects, nutrition (especially protein), weight, and workouts gives you and your doctor a complete picture. OptimizeGLP was built specifically for this — it logs injections, calculates protein targets, tracks side effects, visualizes progress, and generates weekly summaries.

OptimizeGLP links meal plans, medication logs, food databases, medications, and referrals in 142 pages for weight goals, workouts, and reminders.

All Articles

Mounjaro vs Zepbound: What's the Difference?

Both contain tirzepatide — the most effective GLP-1 medication. But one is for diabetes and one is for weight loss. Here's the breakdown.

6 min read · Educational resource

The Short Answer

Mounjaro and Zepbound both contain tirzepatide, a dual GIP/GLP-1 agonist — the most effective weight loss medication class available. Mounjaro is FDA-approved for type 2 diabetes; Zepbound is approved for weight loss. The dosing schedules are identical.

Side-by-Side Comparison

Feature	Mounjaro	Zepbound
Active Ingredient	Tirzepatide	Tirzepatide
Drug Class	GIP/GLP-1 Dual Agonist	GIP/GLP-1 Dual Agonist
Manufacturer	Eli Lilly	Eli Lilly
FDA Approval	Type 2 Diabetes	Chronic Weight Management
Max Dose	15 mg weekly	15 mg weekly
Administration	Weekly injection	Weekly injection
Dosing Schedule	2.5 → 15 mg over 5 steps	2.5 → 15 mg over 5 steps
Avg Weight Loss	~20% (off-label)	~22.5% (on-label)
Insurance Coverage	Often covered for diabetes	Often limited for weight loss

Key Differences

The medications are essentially identical in formulation — the only real difference is the FDA-approved indication and insurance coverage
Mounjaro is more likely to be covered by insurance for diabetes patients
Zepbound is the on-label choice if your primary goal is weight loss (BMI ≥30, or ≥27 with conditions)
Both use the same pen device and the same 5-step dose escalation from 2.5 mg to 15 mg

Which Should You Choose?

🏔️

Choose Mounjaro

Choose Mounjaro if you have type 2 diabetes and want the strongest blood sugar control plus significant weight loss. Insurance is more likely to cover it for diabetic patients.

Full Mounjaro Guide

⚡

Choose Zepbound

Choose Zepbound if your primary goal is weight loss. It's the on-label choice for chronic weight management and offers the highest demonstrated weight loss of any GLP-1 medication.

Full Zepbound Guide

Other Medication Comparisons

💉🎯

Ozempic vs Wegovy

6 min read

💉🏔️

Ozempic vs Mounjaro

7 min read

🎯⚡

Wegovy vs Zepbound

7 min read

💊💉

Rybelsus vs Ozempic

6 min read

Frequently Asked Questions

Are Mounjaro and Zepbound exactly the same?

They contain the same active ingredient (tirzepatide) made by the same manufacturer (Eli Lilly), with the same dosing schedule (2.5 mg to 15 mg). The only difference is the FDA-approved indication: Mounjaro for type 2 diabetes, Zepbound for weight loss. They use the same pen device.

Which produces more weight loss?

Both can produce up to ~22% weight loss since they contain the same drug at the same doses. Clinical trial results are nearly identical. The choice usually comes down to insurance coverage and your diagnosis, not efficacy.

Can I switch between Mounjaro and Zepbound?

Switching is possible under your doctor's guidance. Since the dosing is identical, a switch at the same dose level is generally straightforward. Your doctor will help determine if a switch makes sense based on your insurance coverage and treatment goals.

Why would my doctor prescribe one over the other?

It typically comes down to your diagnosis and insurance. If you have type 2 diabetes, Mounjaro is the on-label choice and more likely to be covered. If you're seeking weight loss without diabetes, Zepbound is the on-label choice. Some doctors prescribe Mounjaro off-label for weight loss if insurance covers it better.

Ready to put this into practice?

OptimizeGLP tracks your medication, nutrition, side effects, and progress — all in one place, built for GLP-1 patients.

Get Started Free Try the Protein Calculator →